Psychedelics and AI promise the next breakthrough treatment for dementia
Spannr - 30-Mar-2023Benefits of psychedelic drugs or AI compounds may outperform clinical drugs with fewer side effects; clinical trials yet to confirm
Join the club for FREE to access the whole archive and other member benefits.
World's most comprehensive source of longevity news and information
We are dedicated to those searching to increase their healthspan and extend their lifespan. From education, to industry data, to product and service analysis, Spannr is here to demystify your health journey and increase the span of your life.
Disruption is coming to healthcare, with emphasis on healthspan and lifespan leading the change. Countless opportunities and challenges will arise in the coming years as economies shift to accommodate changing demographics. Individuals will soon have access to an array of new products and services that can greatly enhance their lives.
But the path to understanding and actively participating in this longevity trend can be complicated. Technical science, conflicting information, and complex data can all be barriers to entry.
Visit website: https://spannr.com/
Details last updated 23-Jun-2023
Business Consultant and Staff Writer at Spannr, Navy Veteran, Entrepreneur and Business Broker
Benefits of psychedelic drugs or AI compounds may outperform clinical drugs with fewer side effects; clinical trials yet to confirm